Fosmidomycin/Azithromycin

膦胺霉素/阿奇霉素

Report date: 2026/03/04 20:01:44

Base Information

Drug NameFosmidomycin/Azithromycin
Drug Alias Name阿奇霉素/膦胺霉素Azithromycin/Fosmidomycinfosmidomycin + azithromycinJP-02
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > Macrolides antibioticsSmall molecules > Heterocyclic drugs
Mechanisms of Action50S ribosomal subunit inhibitorsOxidoreductases inhibitorsProtein biosynthesis inhibitors
Targets50S ribosomal subunitOxidoreductases
Therapy Area/IndicationsMalaria, Falciparum
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes FosmidomycinAzithromycin
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBioagency Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBioagency Ag
Active IndicationsN/A
Inactive IndicationsMalaria, Falciparum

Other Information

ATC CodeN/A
Related LinksN/A